Cutera Receives Additional Approval from Health Canada for its truSculpt® iD Body Sculpting Technology
September 12 2019 - 4:00PM
Business Wire
CUTERA®, INC., (Nasdaq: CUTR) ("Cutera" or the "Company") a
leading provider of laser, light and other energy-based aesthetic
systems for practitioners worldwide, announced today that Health
Canada recently granted regulatory approval expanding the
indications for use for truSculpt® iD to include reduction of
circumference of the abdomen and non-invasive lipolysis (the
permanent removal of fat cells).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190912005123/en/
Before and After with truSculpt® iD Body
Sculpting Technology (Photo: Business Wire)
"Canada is a key market for Cutera and our full aesthetics
technology product line," said Cutera's Chief Executive Officer,
David Mowry. “truSculpt iD’s global popularity among providers and
patients remains strong. This additional approval from Health
Canada reinforces the acknowledgement of the clinical effectiveness
for truSculpt iD to permanently eliminate fat.”
Research shows that noninvasive body sculpting is the #1
non-surgical fat reduction procedure, with a 14.5% increase
year-over-year in body shaping procedures.1,2
The Company launched truSculpt iD in the US and Canada in
2018.
About truSculpt iD
truSculpt is a non-surgical body sculpting treatment that uses
monopolar radiofrequency (RF) technology. It is clinically proven
to get rid of stubborn fat cells permanently by an average of 24%3,
even in areas that are resistant to diet and exercise. truSculpt iD
is clinically proven to eliminate fat in as little as one 15-minute
hands-free treatment, completely personalized to an individual's
needs.
Additional information can be found: trusculpt.com
cutera.com/trusculptiD
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser
and other energy-based aesthetic systems for practitioners
worldwide. Since 1998, Cutera has been developing innovative,
easy-to-use products that enable physicians and other qualified
practitioners to offer safe and effective aesthetic treatments to
their patients. For more information, call +1 415-657-5500 or
1-888-4CUTERA or visit cutera.com.
Sources:
- American Society for Aesthetic Plastic Surgery
- Medical Insight (MII)
- Amy Taub, MD, Study ASDS 2017 Poster
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190912005123/en/
Tanya Rodante Director of Corporate Communications +1
415-657-5500 trodante@cutera.com
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Sep 2023 to Sep 2024